Massachusetts Board Cuts GLP-1 Obesity Drug Coverage For State Workers as Costs Soar
Massachusetts’ Group Insurance Commission voted to end GLP-1 drug coverage for obesity treatment for public employees and retirees, citing rising costs and pressure to rein in state health spending.
